American College of Cardiology – 2019 Dapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58 (Bonaca ACC 2019) Dapafliflozin and CV Outcomes in Patients with T2DM and Prior MI in DECLARE (Furtado ACC 2019) Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus (Kato ACC 2019) Share this:TwitterFacebookLike this:Like Loading...